Phenytoin Testing Market

Phenytoin Testing Market - Global Industry Analysis 2014 - 2018 and Opportunity Assessment 2019 - 2029

  • Ongoing
  • May 2020
  • REP-GB-10560
  • PDF PPT EXCEL
Phenytoin Testing Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Phenytoin Testing market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Phenytoin Testing market.


Phenytoin Testing is employed to determine concentration of Phenytoin in the patient blood samples. The sample screened from the patient offer a brief idea about the selection of the therapeutic level of drug and to plan treatment measures accordingly. The Phenytoin Testing is performed primarily in the hospital facilities specifically in surgical care units, intensive care units, to map the drug level in post-surgery and pre-surgical procedure. The test can be employed to determine the therapeutic efficacy of the phenytoin drug treatment. The Phenytoin Testing offers primeval advantage in preventing renal failure and nervous damage. Thereby, offering new growth opportunities for the phenytoin testing market. The test service providers in the Phenytoin Testing market are highly focused on reducing the time required in obtaining results. The phenytoin testing market displayers a strong competition among its key competitors and are firmly working on test pricing to lure maximum patient pool and carve out considerable market share in the Phenytoin Testing market.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus imapact analysis across industries and markets

Request Covid -19 Impact

Phenytoin Testing Market: Drivers and Restraints

The prominent factor propelling the growth of Phenytoin Testing market is increasing in incidences of Phenytoin toxicity, reasoning to the increasing burden of epilepsy and post-surgical complication causing seizures. According to the data from statistics released by Agency for Healthcare Research and Quality (AHRQ) the prescription rate for phenytoin in 2016 totaled more than 2.75 Mn prescription in US alone. The increasing prescription rate is anticipated to propel the demand for phenytoin testing fuelled by efficacy testing and standard dose control measures. The development in Phenytoin specific reagents and advanced ELISA test are anticipated to drive the growth of the phenytoin testing market. Subsequently, growing services penetration from key service provides is anticipated to fuel the growth of the Phenytoin Testing market. For instance, the growing services in Phenytoin Test from leading diagnostic company, ARUP Laboratories is targeting the product on rapid testing of phenytoin toxicity, which is expected to offer the service provider an edge in Phenytoin Testing market. However irregularity in test results and additional cost Burdon is anticipated to impede the growth of the Phenytoin Testing market.

Phenytoin Testing Market: Overview

The global Phenytoin Testing market is projected to exhibit significant growth reasoning to higher level of pathological significance of the test for healthcare professional and patient. Higher preferences for point of care testing and its turnaround time for result are among the major factors that are anticipated to propel the growth for Phenytoin Testing market. Specifically, preventive Phenytoin Testing for toxicity check is anticipated to show substantial growth rate. The recent data released by world health organization (WHO) approximately more than 50 Mn people around the globe are affected with epilepsy, emerging as most prevalent neurological disorder globally. The higher consumption of phenytoin is directly related to increasing incidence of drug toxicity and safe drug dose management. Thus, anticipated to drive the demand for phenytoin testing. Additionally, initiatives by non-government organization to raise awareness for drug adherence and drug abuse testing in anticipated to propel the growth of the Phenytoin Testing market.

Phenytoin Testing Market: Region-Wise Overview

The Global Phenytoin Testing market is segmented into the following regions - North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa. North America is prominent regional market for Phenytoin Testing due to high prescription rate, wide range of pathological test availability and developed health care infrastructure in the region. In East Asia, China is prominent Phenytoin Testing market due to widespread adoption of Phenytoin Testing additionally higher incidence of epilepsy. Latin America Phenytoin Testing market is anticipated to shoe sluggish growth rate owing to low adoption rate for Phenytoin toxicity testing. South Asia is anticipated to exhibit higher growth rate due to higher renal failure rate in epileptic patients around the region. Growth in Middle East and Africa is stagnant as slow growth in the healthcare standards in the region.

Phenytoin Testing Market: Key Participants

Examples of some of the key participants in the Phenytoin Testing market are Roche Molecular Systems Inc, Abbott Diagnostics, ARUP Laboratories, Quest Diagnostics, Lybrate Inc, denka seiken co. Ltd., and Portea Medical. Among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Phenytoin Testing Market Segments
  • Phenytoin Testing Market Dynamics
  • Phenytoin Testing Market Size
  • Phenytoin Testing Market Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The regional analysis includes:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Phenytoin Testing Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Phenytoin Testing Market: Segmentation

Based on product type Phenytoin Testing market is further segmented into:

  • Laboratory tests
  • Test kits
  • Reagent
  • Accessories

Based on End User Phenytoin Testing market is further segmented into:

  • Hospitals
  • Pathology laboratories
  • Research Centers
  • Clinics

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Phenytoin Testing Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Phenytoin Testing Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology